Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
OtherClinical Investigations (Human)

Quality of life in patients with metastatic gastroenteropancreatic neuroendocrine tumors receiving peptide receptor radionuclide therapy: information from a monitoring program in clinical routine

Caroline Martini, Sabine Buxbaum, Margarida Rodrigues, Bernhard Nilica, Lorenza Scarpa, Bernhard Holzner, Irene Virgolini and Eva-Maria Gamper
Journal of Nuclear Medicine July 2018, jnumed.117.204834; DOI: https://doi.org/10.2967/jnumed.117.204834
Caroline Martini
1 Medical University of Innsbruck, Austria;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sabine Buxbaum
1 Medical University of Innsbruck, Austria;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Margarida Rodrigues
1 Medical University of Innsbruck, Austria;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bernhard Nilica
1 Medical University of Innsbruck, Austria;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lorenza Scarpa
1 Medical University of Innsbruck, Austria;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bernhard Holzner
1 Medical University of Innsbruck, Austria;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Irene Virgolini
1 Medical University of Innsbruck, Austria;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eva-Maria Gamper
2 Innsbruck Institute of Patient-centered Outcome Research, Austria
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

jnumed.117.204834
DOI 
https://doi.org/10.2967/jnumed.117.204834
PubMed 
30042164

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online July 24, 2018.

Article Versions

  • You are currently viewing a previous version of this article (July 24, 2018 - 10:34).
  • View the most recent version of this article
Copyright & Usage 
Copyright © 2018 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Author Information

  1. Caroline Martini1,
  2. Sabine Buxbaum1,
  3. Margarida Rodrigues1,
  4. Bernhard Nilica1,
  5. Lorenza Scarpa1,
  6. Bernhard Holzner1,
  7. Irene Virgolini1 and
  8. Eva-Maria Gamper2
  1. 1 Medical University of Innsbruck, Austria;
  2. 2 Innsbruck Institute of Patient-centered Outcome Research, Austria
  1. For correspondence or reprints contact: Eva-Maria Gamper, Innsbruck Institute of Patient-centered Outcome Research, Dr. Stumpf Straße 56, Innsbruck 6020, Austria. E-mail: eva.gamper@iipcor.org

Statistics from Altmetric.com

Cited By...

  • 14 Citations
  • 15 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Peptide Receptor Radiotherapy: Current Approaches and Future Directions
    Grace Kong, Rodney J. Hicks
    Current Treatment Options in Oncology 2019 20 10
  • Quality of Life in Patients with Neuroendocrine Neoplasms: The Role of Severity, Clinical Heterogeneity, and Resilience
    Cristiano Scandurra, Roberta Modica, Nelson Mauro Maldonato, Pasquale Dolce, Greta G Dipietrangelo, Roberta Centello, Valentina Di Vito, Filomena Bottiglieri, Federica de Cicco, Elisa Giannetta, Andrea M Isidori, Andrea Lenzi, Benedetta Muzii, Antongiulio Faggiano, Annamaria Colao
    The Journal of Clinical Endocrinology & Metabolism 2021 106 1
  • Quality of life in patients with midgut NET following peptide receptor radionuclide therapy
    Milka Marinova, Martin Mücke, Felix Fischer, Markus Essler, Henning Cuhls, Lukas Radbruch, Shiwa Ghaei, Rupert Conrad, Hojjat Ahmadzadehfar
    European Journal of Nuclear Medicine and Molecular Imaging 2019 46 11
  • The Challenge of Evaluating Response to Peptide Receptor Radionuclide Therapy in Gastroenteropancreatic Neuroendocrine Tumors: The Present and the Future
    Virginia Liberini, Martin W. Huellner, Serena Grimaldi, Monica Finessi, Philippe Thuillier, Alfredo Muni, Riccardo E. Pellerito, Mauro G. Papotti, Alessandro Piovesan, Emanuela Arvat, Désirée Deandreis
    Diagnostics 2020 10 12
  • Evaluation of 177Lu-Dotatate treatment in patients with metastatic neuroendocrine tumors and prognostic factors
    Estephany Abou Jokh Casas, Virginia Pubul Núñez, Urbano Anido-Herranz, María del Carmen Mallón Araujo, Maria del Carmen Pombo Pasín, Miguel Garrido Pumar, José Manuel Cabezas Agrícola, José Manuel Cameselle-Teijeiro, Ashraf Hilal, Álvaro Ruibal Morell
    World Journal of Gastroenterology 2020 26 13
  • Health-related quality of life in patients with neuroendocrine neoplasms: a two-wave longitudinal study
    R. Modica, C. Scandurra, N. M. Maldonato, P. Dolce, G. G. Dipietrangelo, R. Centello, V. Di Vito, E. Giannetta, A. M. Isidori, A. Lenzi, A. Faggiano, A. Colao
    Journal of Endocrinological Investigation 2022 45 11
  • Quality of life in patients with gastroenteropancreatic tumours: A systematic literature review
    Catherine Watson, Craig William Tallentire, John K Ramage, Rajaventhan Srirajaskanthan, Oscar R Leeuwenkamp, Donna Fountain
    World Journal of Gastroenterology 2020 26 25
  • Finding the Appropriate Therapeutic Strategy in Patients with Neuroendocrine Tumors of the Pancreas: Guideline Recommendations Meet the Clinical Reality
    Sebastian Krug, Marko Damm, Jakob Garbe, Senta König, Rosa Lynn Schmitz, Patrick Michl, Jörg Schrader, Anja Rinke
    Journal of Clinical Medicine 2021 10 14
  • Initial experience and lessons learned with implementing Lutetium-177-dotatate radiopharmaceutical therapy in a radiation oncology–based program
    Nichole M. Maughan, Hyun Kim, Yao Hao, Samantha Unangst, Michael C. Roach, Jose L. Garcia-Ramirez, Max Amurao, David Luechtefeld, Kinda Abdin, Michael B. Altman, Alexis Banks, Mary Riepe, Erica Bovard, Samantha Jenkins, Jacqueline E. Zoberi
    Brachytherapy 2021 20 1
  • Theragnostics in Neuroendocrine Tumors
    Margarida Rodrigues, Hanna Svirydenka, Irene Virgolini
    PET Clinics 2021 16 3

Article usage

Article usage: July 2018 to August 2023

AbstractFullPdf
Jul 2018243024
Aug 2018282021
Sep 2018121014
Oct 2018124369178
Nov 20182062127
Dec 20181021723
Jan 20191241622
Feb 2019501413
Mar 2019532517
Apr 201939920
May 2019372831
Jun 201931369
Jul 2019442830
Aug 201935713
Sep 2019301820
Oct 2019292719
Nov 2019351719
Dec 2019182016
Jan 202023178
Feb 2020161919
Mar 2020171116
Apr 2020161315
May 2020232615
Jun 2020231912
Jul 202031823
Aug 20209510
Sep 2020251422
Oct 2020252133
Nov 20201136
Dec 2020162213
Jan 2021162630
Feb 2021232126
Mar 2021242917
Apr 202126287
May 2021213331
Jun 2021163012
Jul 2021101726
Aug 2021102016
Sep 20211375
Oct 202151323
Nov 2021102028
Dec 20219225
Jan 20229298
Feb 202262613
Mar 2022101215
Apr 2022202213
May 2022571912
Jun 2022351810
Jul 202210259
Aug 202251410
Sep 2022461422
Oct 202213269
Nov 2022101620
Dec 2022773
Jan 202382815
Feb 20234197
Mar 2023676
Apr 20238297
May 2023589
Jun 20234169
Jul 202321110
Aug 20237815
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 64 (9)
Journal of Nuclear Medicine
Vol. 64, Issue 9
September 1, 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Quality of life in patients with metastatic gastroenteropancreatic neuroendocrine tumors receiving peptide receptor radionuclide therapy: information from a monitoring program in clinical routine
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Quality of life in patients with metastatic gastroenteropancreatic neuroendocrine tumors receiving peptide receptor radionuclide therapy: information from a monitoring program in clinical routine
Caroline Martini, Sabine Buxbaum, Margarida Rodrigues, Bernhard Nilica, Lorenza Scarpa, Bernhard Holzner, Irene Virgolini, Eva-Maria Gamper
Journal of Nuclear Medicine Jul 2018, jnumed.117.204834; DOI: 10.2967/jnumed.117.204834

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Quality of life in patients with metastatic gastroenteropancreatic neuroendocrine tumors receiving peptide receptor radionuclide therapy: information from a monitoring program in clinical routine
Caroline Martini, Sabine Buxbaum, Margarida Rodrigues, Bernhard Nilica, Lorenza Scarpa, Bernhard Holzner, Irene Virgolini, Eva-Maria Gamper
Journal of Nuclear Medicine Jul 2018, jnumed.117.204834; DOI: 10.2967/jnumed.117.204834
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

Similar Articles

Keywords

  • Neuroendocrine
  • Oncology: General
  • Radionuclide Therapy
  • Statistical Analysis
  • clinical practice
  • gastroenteropancreatic neuroendocrine tumours
  • health-related quality of life
  • peptide receptor radionuclide therapy
  • routine monitoring
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire